Chimigen Bio announced that it has raised over CNY 100 million in a round of funding led by Lapam Capital on September 22, 2022. The transaction also included participation from Zhejiang Puhua Tianqin Equity Investment Management Co., Ltd., Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd and other institutes and angel investors. The round was oversubscribed.